Akron Biotech Attends the MIT Center for Biomedical Innovation’s 2018 BioMAN Summit in Cambridge

The MIT Center for Biomedical Innovation (CBI) leads the Biomanufacturing (BioMAN) program, an initiative that joins leaders from industry, academia, and government to address collective challenges in biologics manufacturing by creating a pre-competitive environment in which stakeholders can share best practices and engage in collaborative work. Akron Biotech attended this year’s summit in Cambridge, MA

American Society of Hematology Annual Meeting highlights the promise of CAR-T cell therapy

The 60th Annual American Society of Hematology Annual Meeting in San Diego featured a number of presentations that highlighted the promise of CAR-T therapy. Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center reported promising early results from a Phase Ib/II clinical trial that used autologous CAR-T cells to recognize and fight Hodgkin

Join Akron at SITC 2018

This week, from Wednesday November 7 through Sunday November 11, Akron Biotech representatives will be attending the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. SITC 2018 is the leading destination for scientific exchange, education and networking in the cancer immunotherapy field. As an innovative

Upcoming Events – September 2018

As a scorching summer draws to a close and conference season begins, Akron will be participating at many upcoming events to further advocate for the use of higher quality ancillary materials in regenerative medicine processes.  Our focus of providing affordable cGMP reagents throughout the development stages for these unique therapeutics serves to better ensure reproducibility

Akron co-sponsors the 11th annual Business of Regenerative Medicine Symposium at the University of Pennsylvania

The 11th annual Business of Regenerative Medicine: Innovation, Clinical Translation, and Entrepreneurship Symposium took place on July 17th-18th. The event was hosted by the Center for Cellular Immunotherapies and the Institute for Regenerative Medicine at the University of Pennsylvania in partnership with Case Western Reserve University, the Harvard Stem Cell Institute, the Parker H. Petit

Join Akron at ISCT 2018

Riding the commercial approvals of two CAR T immunotherapies last year, the energized regenerative medicine community will be coming together in Montreal for the Annual ISCT Global Meeting and Exhibition from Wednesday May 2nd through Saturday May 5th. Don’t miss Dr. Claudia Zylberberg, CEO of Akron Biotech, during the Quality & Operations Track speaking about

Innate Killer Summit 2018 presents cutting-edge innovations and the latest clinical data for NK cell therapies

Akron Biotech was proud to be a sponsor of this year’s Innate Killer Summit held in San Diego, California. The Innate Killer Summit is the leading, dedicated end-to-end meeting serving as a catalyst to ensure successful clinical and commercial translation of NK cell immunotherapies. The most current and advanced clinical data was presented as well

Akron CEO Zylberberg interviewed for the Innate Killer Summit 2018

The Innate Killer Summit is the leading, dedicated end-to-end meeting serving as the catalyst to ensure successful clinical and commercial translation of Natural Killer (NK) cell immunotherapies. Leading up to the March 2018 event in San Diego, CA, Akron Biotechnology CEO Claudia Zylberberg, Ph.D. shared some key issues and questions arising in the NK therapy